GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synergy Innovation Co Ltd (XKRX:048870) » Definitions » Current Ratio

Synergy Innovation Co (XKRX:048870) Current Ratio : 2.41 (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Synergy Innovation Co Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Synergy Innovation Co's current ratio for the quarter that ended in Dec. 2023 was 2.41.

Synergy Innovation Co has a current ratio of 2.41. It generally indicates good short-term financial strength.

The historical rank and industry rank for Synergy Innovation Co's Current Ratio or its related term are showing as below:

XKRX:048870' s Current Ratio Range Over the Past 10 Years
Min: 0.23   Med: 1.16   Max: 2.46
Current: 2.41

During the past 13 years, Synergy Innovation Co's highest Current Ratio was 2.46. The lowest was 0.23. And the median was 1.16.

XKRX:048870's Current Ratio is ranked worse than
63.84% of 1554 companies
in the Biotechnology industry
Industry Median: 3.79 vs XKRX:048870: 2.41

Synergy Innovation Co Current Ratio Historical Data

The historical data trend for Synergy Innovation Co's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synergy Innovation Co Current Ratio Chart

Synergy Innovation Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.89 1.24 1.23 1.67 2.41

Synergy Innovation Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.67 1.86 3.61 4.32 2.41

Competitive Comparison of Synergy Innovation Co's Current Ratio

For the Biotechnology subindustry, Synergy Innovation Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synergy Innovation Co's Current Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Synergy Innovation Co's Current Ratio distribution charts can be found below:

* The bar in red indicates where Synergy Innovation Co's Current Ratio falls into.



Synergy Innovation Co Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Synergy Innovation Co's Current Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Current Ratio (A: Dec. 2023 )=Total Current Assets (A: Dec. 2023 )/Total Current Liabilities (A: Dec. 2023 )
=147747.009/61184.028
=2.41

Synergy Innovation Co's Current Ratio for the quarter that ended in Dec. 2023 is calculated as

Current Ratio (Q: Dec. 2023 )=Total Current Assets (Q: Dec. 2023 )/Total Current Liabilities (Q: Dec. 2023 )
=147747.009/61184.028
=2.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Synergy Innovation Co  (XKRX:048870) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Synergy Innovation Co Current Ratio Related Terms

Thank you for viewing the detailed overview of Synergy Innovation Co's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Synergy Innovation Co (XKRX:048870) Business Description

Traded in Other Exchanges
N/A
Address
124 Myeong-dong Dong 601, Seongnam-si, Gyeonggi-do, Seoul, KOR
Synergy Innovation Co Ltd is a South Korean company engaged in research and development in various fields like genetics, new drugs, and medical devices and materials. The business of the company includes bio business and new drug development.

Synergy Innovation Co (XKRX:048870) Headlines

No Headlines